SCHEMBL7045677

SCHEMBL7045677

Cc1cccnc1C(=O)NO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.46
HDAC6 Q9UBN7 3/20 0.46
KDM4E B2RXH2 4/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
KMT2A Q03164 1/20 0.45
KIT P10721 1/20 0.44
FDPS P14324 2/20 0.44
P2RX7 Q99572 1/20 0.43
GRM5 P41594 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC2 Q92769 1/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30695551 0.85 PLK1 (0.46) KDM4EL3MBTL1KMT2AKITFDPS
SCHEMBL8568914 0.85 PLK1 (0.46) KDM4EL3MBTL1KMT2AKITFDPS
SCHEMBL10517292 0.83 GRM5 (0.45) KDM4EL3MBTL1KMT2AKITFDPS
SCHEMBL109198 0.83 P2RX7 (0.59) KDM4EL3MBTL1KMT2AKITFDPS
SCHEMBL24571662 0.81 CTSA (0.49) KDM4EL3MBTL1KMT2AKITFDPS
SCHEMBL13310736 0.80 PARP1 (0.48) KDM4EL3MBTL1KMT2AKITP2RX7
SCHEMBL30853475 0.80 SMN1; SMN2 (0.48) KDM4EL3MBTL1KMT2AKITFDPS
SCHEMBL4605525 0.80 SMN1; SMN2 (0.48) KDM4EL3MBTL1KMT2AKITFDPS
SCHEMBL28151967 0.80 POLB (0.50) KDM4EL3MBTL1KMT2AKITNPC1
SCHEMBL162188 0.80 L3MBTL1 (0.50) KDM4EL3MBTL1KMT2AP2RX7NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8742123-B2 HIV integrase inhibitors from pyridoxine TAIMED BIOLOGICS, INC. (TW) 2014-06-03 US disclosed
WO-2004110351-A2 HETEROCYCLIC COMPOUNDS FOR TREATING HEPATITIS C VIRUS ANADYS PHARMACEUTICALS, INC. (US) 2004-12-23 WO disclosed